Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

522 trials

2024-519890-21-00
Recruiting
PROSPECTIVE RANDOMISED CLINICAL TRIAL TO EVALUATE THE EARLY RECURRENCE RATE IN NON-MUSCLE INVASIVE BLADDER CANCER BETWEEN THE USE OF CHEMOHYPERTHERMIA (QH) WITH MITOMYCIN-C PRIOR TO TRANSURETHRAL BLADDER RESECTION IN A MAJOR OUTPATIENT SURGERY PROGRAMME AND TREATMENT WITH MITOMYCIN-C IN NORMOTHERMIA POST-RESECTION.
Phase 4 · Spain · 1 site
Registry update: 28 Nov 2024
NCT06630416
Recruiting
Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors
Phase 2 · United States · 2 sites
Registry update: 12 Jun 2026
NCT05656235
Recruiting
Renal Retention in High Grade Upper Tract Urothelial Cancer
Phase 2 · United States · 2 sites
Registry update: 8 Jan 2026
NCT06703476
Recruiting
A Study of Surgical Techniques During Cystectomy
Phase 3 · United States · 7 sites
Registry update: 22 Sept 2026
NCT06281080
Recruiting
Performance, Feasibility, and Safety Study for a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours: First-In-Human Trial
Not applicable · Hong Kong · 1 site
Registry update: 3 Nov 2026
NCT06683846
Recruiting
Ivonescimab in the Treatment of Multiple Advanced Tumors
Phase 2 · China · 1 site
Registry update: 24 Aug 2025
NCT06388720
Recruiting
The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy
Phase 2 · South Korea · 1 site
Registry update: 29 May 2026
NCT06682728
Recruiting
Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence
Phase 2 · United States · 1 site
Registry update: 30 Apr 2026
NCT06644755
Recruiting
First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
Phase 1 · Belgium, France, South Korea, Netherlands, United States · 7 sites
Registry update: 4 Sept 2026
NCT06632262
Recruiting
A Phase 2 Clinical Study of ABSK061 and ABSK043
Phase 2 · China · 21 sites
Registry update: 19 Nov 2024
NCT06595446
Recruiting
A Feasibility Randomized Trial Evaluating Early vs Late Stent Removal Following Radical Cystectomy and Ileal Conduit Formation for Bladder Cancer
Not applicable · Canada · 1 site
Registry update: 4 Apr 2025
NCT06488222
Recruiting
Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer
Phase 2 · United States · 1 site
Registry update: 11 Mar 2026
NCT07359235
Recruiting
Safety, Tolerability, and Preliminary Efficacy of KD01 Via Intravesical Instillation in Bladder Cancer (BC)
Phase 1 · China · 1 site
Registry update: 22 Jan 2026
NCT06639347
Recruiting
A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma
Phase 1/2 · China · 1 site
Registry update: 18 Nov 2024
NCT06988696
Recruiting
The Effect of Perioperative Heated Sock Application on Hypothermia and Vital Signs in Bladder Tumor Surgery
Not applicable · 1 site
Registry update: 25 May 2025
NCT06434350
Recruiting
Enfortumab Vedotin With Radiation for Locally Advanced Bladder Cancer (CONSOLIDATE)
Phase 1/2 · United States · 1 site
Registry update: 15 Jun 2026
NCT06719232
Recruiting
Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical Instillation
Not applicable · Hungary · 2 sites
Registry update: 12 Dec 2024
NCT06662071
Recruiting
A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology
Not applicable · China · 17 sites
Registry update: 28 Oct 2024
NCT06545955
Recruiting
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
Phase 3 · Canada, Czechia, Denmark, Spain, France, Italy, South Korea, Poland, United States · 86 sites
Registry update: 30 Oct 2026
NCT06510374
Recruiting
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
Phase 3 · Canada, Czechia, Denmark, Spain, France, Italy, Japan, South Korea, Poland, United States · 116 sites
Registry update: 30 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.